載入...
Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist
Nonpeptide thrombopoietin receptor (TPOR/MPL) agonists, such as eltrombopag, have been used to treat thrombocytopenia of various aetiologies. Here, we investigated the pharmacological properties of hetrombopag, a new orally active small‐molecule TPOR agonist, in preclinical models. Hetrombopag speci...
Na minha lista:
| 發表在: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6201220/ https://ncbi.nlm.nih.gov/pubmed/30156363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13809 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|